1. Mechanism of immunotherapeutic activity of OK-432 in the treatment of peritoneal carcinomatosis

   • Hiroyasu Fukui
   • Craig W. Reynolds
   • James E. Talmadge

   Original Articles Pages: 1 - 6

2. Role of respiratory-burst products from polymorphonuclear leukocytes in the antitumor activity of Propionibacterium acnes vaccine

   • Elsa A. Murano
   • Cecil S. Cummins

   Original Articles Pages: 7 - 16

3. The anticancer drug, cisplatin, increases the naturally occurring cell-mediated lysis of tumor cells

   • John Leslie Collins
   • Ming-Shian Kao

   Original Articles Pages: 17 - 22

4. Synergic action between tumor necrosis factor and endotoxins or poly(A·U) on cultured bovine endothelial cells

   • Paul A. van de Wiel
   • Raymond H. H. Pieters
   • Nanne Bloksma

   Original Articles Pages: 23 - 28

5. In vitro modulation of leucocyte-function-associated antigen-1 expression on two leukemic cell lines

   • Anne Altmeyer
   • Christiane Moog
   • Pierre Bischoff

   Original Articles Pages: 29 - 34

6. Production of cytokines after lipopolysaccharide stimulation of murine spleen cells during lymphoma development in AKR mice

   • Vaillier D.
   • Daculsi R.
   • Guillemain B.

   Original Articles Pages: 35 - 42

7. A preliminary pharmacokinetic study of ¹¹¹In-labeled 260F9 anti-(breast cancer) antibody in patients

   • Thomas W. Griffin
   • Faran Bokhari
   • John Wilson

   Original Articles Pages: 43 - 50

8. Discontinuing therapy in childhood acute lymphoblastic leukemia treated with a chemoimmunotherapy protocol

   • Yoshihiro Komada
   • Eiichi Azuma
   • Tadasu Izawa

   Original Articles Pages: 51 - 56

9. Monocyte-dependent, serum-borne suppressor of induction of lymphokine-activated killer cells in lymphocytes from melanoma patients

   • Kyogo Itoh
   • Neal R. Pellis
   • Charles M. Balch

   Original Articles Pages: 57 - 62

10. Partial correction of defective generation of lymphokine-activated killer cells in patients with chronic myelogenous leukaemia after in vivo treatment with interferon-α (wellferon)

    • Graham Pawelec
    • Edwin Schneider
    • Helmut Schmidt

    Original Articles Pages: 63 - 66

11. Large-scale preparation of adherent lymphokine-activated killer (A-LAK) cells for adoptive immunotherapy in man

    • Robert J. Melder
    • Craig S. Rosenfeld
    • Theresa L. Whiteside

    Original Articles Pages: 67 - 73

12. Chemo-immunotherapy of murine tumors using interleukin-2 (IL-2) and cyclophosphamide

    • Eli Kedar
    • Revital Ben-Aziz
    • Benny Leshem

    Short Communication Pages: 74 - 78

13. Meeting announcement

    Announcement Pages: A3 - A3